Lineage Cell Therapeutics Inc (NYSE American:LCTX)

0.9509
Delayed Data
As of 3:49pm ET
 -0.0175 / -1.81%
Today’s Change
0.93
Today|||52-Week Range
1.58
-18.73%
Year-to-Date
No recent news for Lineage Cell Therapeutics Inc.

Today’s Trading

Previous close0.97
Today’s open0.95
Day’s range0.95 - 0.98
Volume560,659
Average volume (3 months)445,028
Market cap$171.6M
Data as of 3:49pm ET, 11/28/2023

Growth & Valuation

Earnings growth (last year)+40.84%
Earnings growth (this year)-16.19%
Earnings growth (next 5 years)+2.00%
Revenue growth (last year)+277.39%
P/E ratioNM
Price/Sales13.51
Price/Book2.27

Competitors

 Today’s
change
Today’s
% change
VSTMVerastem Inc-0.22-3.36%
HARPHarpoon Therapeutics...+0.74+7.60%
RIGLRigel Pharmaceutical...+0.05+5.05%
XOMAXOMA Corp+0.14+0.94%
Data as of 3:59pm ET, 11/28/2023

Financials

Next reporting dateMarch 14, 2024
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$14.7M
Annual profit (last year)-$26.3M
Net profit margin-178.69%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Carlsbad, California

Forecasts